蛋白

Recombinant Human TNF-alpha Hyperactive Mutant Protein

8599-TA-010

10微克

226美元

8599-TA

8599-TA-010

Recombinant Human TNF-alpha Hyperactive Mutant Protein

The Recombinant Human TNF-alpha Hyperactive Mutant Protein from R&D Systems is derived from E. coli. The Recombinant Human TNF-alpha Hyperactive Mutant Protein has been validated for the following applications: Bioactivity.

肿瘤坏死因子甲

蛋白和酶

10微克

Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.

未共轭

>95%, by SDS-PAGE with silver staining.

人类

16 kDa, reducing conditions

17 kDa

肿瘤坏死因子

Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED50 for this effect is 2.5-12.5 pg/mL.

<0.10 EU per 1 µg of the protein by the LAL method.

P01375

Bioactivity

E. coli-derived Recombinant Human TNF-alpha Hyperactive Mutant Protein

Mutant form with approximately 5-fold greater activity

226美元

Mutant form with approximately 5-fold greater activity

APC1 protein, Cachectin, Cachetin, DIF, TNF, TNF, monocyte-derived, TNF-a, TNFA, TNFalpha, TNF-alphacachectin, TNFATNF, macrophage-derived, TNFG1F, TNFSF1A, TNFSF2, TNFSF2TNF superfamily, member 2, tumor necrosis factor, tumor necrosis factor (TNF superfamily, member 2), tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.